Education
About Us
Working with TipRanks
Follow Us
BioAtla (BCAB)
NASDAQ:BCAB
Ba3182
Advanced Adenocarcinoma
Phase I
Recruiting
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Mar 17, 2023
―
Pembrolizumab, Cetuximab, Ozuriftamab Vedotin, Evalstotug (Ba3071)
Metastatic Cancer, Head And Neck Cancer, Squamous Cell Carcinoma Of Head And Neck, Recurrent Squamous Cell Carcinoma Of The Head And Neck, Metastatic Squamous Cell Carcinoma Of The Head And Neck
Phase II
Completed
A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Feb 28, 2022
―
Pembrolizumab, Nivolumab, Ba3071, Pemetrexed (Alimta)
Melanoma, Nsclc
Phase I/II
Active Not Recruiting
A Phase 1/2 Study of BA3071 in Patients With Solid Tumors
Dec 14, 2021
―
Pd-1 Inhibitor, Cab-Axl-Adc
Non-Small-Cell Lung Cancer
Phase II
Completed
CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC
Dec 08, 2020
―
Pd-1 Inhibitor, Cab-Ror2-Adc
Melanoma, Non Small Cell Lung Cancer, Triple Negative Breast Cancer, Head And Neck Cancer
Phase I/II
Completed
CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2)
Apr 12, 2018
―
Pd-1 Inhibitor, Cab-Axl-Adc
Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma
Phase I/II
Completed
CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma
Jan 22, 2018
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does BioAtla (BCAB) have in its pipeline
BCAB is currently developing the following drugs: Ba3182, Pembrolizumab, Cetuximab, Ozuriftamab Vedotin, Evalstotug (Ba3071), Pembrolizumab, Nivolumab, Ba3071, Pemetrexed (Alimta). These drug candidates are in various stages of clinical development as the company works toward FDA approval.